Exclusive ResurFX launch ‘huge success’, says Lumenis

By Laura Casewell The official launch of ResurFX took place on March 19th, with key players from the industry gathering at a top Harley Street...

Surge in non-surgical fat-removal

According to new statistics released by the American Society for Aesthetic Plastic Surgeons (ASAPS), the demand for non-surgical fat-removal procedures rose by 43% in...

Research aims to refine buttock augmentation and labiaplasty

Gluteoplasty and labiaplasty, two of the fastest growing plastic surgery procedures, have been examined for new insights into their use and outcomes. The findings...

Pressure to have plastic surgery affects 20% of Northern Irish people

Figures released by BAPRAS find that almost 20% of people in Northern Ireland feel pressure to undergo cosmetic surgery – the highest proportion in...

One in five US women pursuing cosmetic surgery

By Rosie Wilson New research conducted on behalf of RealSelf by Zeitgeist Research has found that 20% of women in the USA are currently pursuing...

New, less invasive bariatric surgery developed

By Rosie Wilson Primary Obesity Surgery Endolumenal might be the newest solution to weight-loss surgery, and is being touted as a far less invasive and...

NURISS launches new serum

By Rosie Wilson NURISS Vitamin B, C, E & Ferulic Infusion Serum (£100, 30ml) is the newest edition to the NURISS skincare range. The serum...

Medical board proposes new cosmetic surgery constraints

By Rosie Wilson The Medical Board of Australia has proposed a set of new guidelines that, if approved, would mean prospective patients of cosmetic surgery...

HealthXchange launches online pharmacy

By Rosie Wilson HealthXchange Pharmacy, a medical supplier company, has launched an online prescription service, which will allow practitioners to process prescriptions online, create and...

FDA panel backs anti double chin drug

By Rosie Wilson ATX-101, a non-surgical solution to double chins developed by Kythera Biopharmaceuticals Inc., has been unanimously backed by an FDA advisory panel, according...